72 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
. The Company owns or has a valid right to access and use all computer systems, networks, hardware, software, databases, websites and equipment used … where the failure to own or have the right to access the Company IT Systems would not reasonably be expected to have a Material Adverse Effect
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
Westchester Ave., Purchase, New York 10577, Attn: Chief Executive Officer.
You also may access these filings on our website at www.cogrx.com. We do … that we specifically incorporate by reference into this prospectus supplement or the accompanying prospectus). You may also access these filings
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
, Attn: Chief Executive Officer.
You also may access these filings on our website at www.cogrx.com. We do not incorporate the information on our website … by reference into this prospectus supplement or the accompanying prospectus). You may also access these filings at the SEC’s website at www.sec.gov.
Any
8-K
EX-10.1
r83ah3
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
zuwknb7c
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
8sihdp1t helbwvs
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
3c6i c37ns
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
z5f7mtr7nvb
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
8vcb8eb9ga7 4w47cmof
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
k7i hoocp8cdzu
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
xog6ojx2
23 Dec 22
Shelf registration
4:16pm